Congruence Therapeutics to Participate at the 3rd Annual Needham Private Biotech Company Virtual 1×1 Forum By Araceli Richardson|2023-10-10T13:06:36-07:0010.10.2023|News|0 Comments Read More
Congruence Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference By Araceli Richardson|2023-09-06T05:04:09-07:0009.06.2023|News|0 Comments Read More
Congruence Therapeutics Announces Presentations at the 2023 European and North America CCG UGM & Conferences By Araceli Richardson|2023-05-25T05:05:14-07:0005.25.2023|News|0 Comments Read More
Congruence Therapeutics to Present at Multiple Investor Conferences in May By Araceli Richardson|2023-05-04T13:58:39-07:0005.04.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference By Araceli Richardson|2023-05-04T13:59:16-07:0004.12.2023|News|0 Comments Read More
Congruence Thérapeutique annonce l’extension de sa ronde de financement de série A, ce qui porte le total des investissements à plus de 65 millions de $ US By Araceli Richardson|2023-07-06T09:54:37-07:0003.06.2023|French News|0 Comments Read More
Congruence Therapeutics Announces Close of Series A Extension, Bringing Total Round to Over US$65 Million By Araceli Richardson|2023-03-06T05:02:41-08:0003.06.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the January 2023 Biotech Showcase in San Francisco By Araceli Richardson|2023-01-29T08:43:59-08:0012.07.2022|News|0 Comments Read More
Congruence Therapeutics fera une présentation lors de l’édition 2023 du Biotech Showcase qui aura lieu en janvier à San Francisco By Araceli Richardson|2023-01-29T08:46:20-08:0012.07.2022|French News|0 Comments Read More
Congruence Therapeutics Strengthens Leadership Team with Appointment of Dr. Sharath Hegde as Chief Scientific Officer By Araceli Richardson|2023-01-29T09:04:19-08:0011.22.2022|News|0 Comments Read More
